| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 20:54 | Johnson & Johnson reports phase 1b prostate cancer trial results | ||
| 20:54 | Oppenheimer raises Frontdoor stock price target on strong renewals | ||
| 20:54 | RBC Capital raises Martin Marietta stock price target on asset deal | ||
| 20:54 | Jefferies cuts iQIYI stock price target on softer content outlook | ||
| 20:42 | Grifols FY 2025 slides: IG growth drives guidance beat despite albumin drag | ||
| 20:30 | Ducommun Q4 2025 slides: record margins, defense surge mask revenue miss | ||
| 20:30 | Teleperformance FY 2025 slides: AI push accelerates amid FX headwinds | ||
| 20:30 | Valeo 2025 slides: record cash flow amid automotive headwinds | ||
| 20:30 | Banco Comercial Português 2025 slides: net income tops €1B milestone | ||
| 20:30 | CSX raises quarterly dividend 8% to $0.14 per share | ||
| 20:30 | Belfry partners with Willis to offer insurance for security firms | ||
| 20:30 | New Era Energy signs LOI to acquire 54 acres in Texas | ||
| 20:30 | Goldman Sachs reiterates Sell rating on Intellia stock amid clinical hold | ||
| 20:30 | TD Cowen reiterates BioCryst Pharma stock Buy rating on Orladeyo growth | ||
| 20:30 | Canaccord reiterates Illumina stock Hold rating after Roche pricing | ||
| 20:30 | Scotiabank reiterates Vistra Energy stock rating on strong outlook | ||
| 20:30 | Stifel reiterates Tango Therapeutics stock rating at Buy | ||
| 20:30 | Intellia stock rating reiterated at Buy by TD Cowen on HAE data | ||
| 20:30 | Raymond James raises Canadian Imperial Bank price target on higher earnings outlook | ||
| 20:30 | Wolfe Research reiterates Peerperform on Bentley Systems stock | ||
| 20:30 | RBC Capital reiterates Nvidia stock Outperform rating at $250 target | ||
| 20:30 | Clear Street lowers Delcath Systems stock price target on revised revenue outlook | ||
| 20:06 | Eaton raises quarterly dividend 6% to $1.10 per share | ||
| 20:06 | Sempra 2025 slides: $65B capital plan targets 11% rate base growth | ||
| 20:06 | Leerink cuts Certara stock price target on weak bookings, guidance |